Jim Meliezer: Aspirin May Help Prevent Recurrent Preterm Birth
Jim Meliezer, Arts-onderzoeker in Amsterdam UMC shared a post on LinkedIn about a recent article by James A. L. Meliëzer et al, published in BJOG, adding:
“Our paper is out!
In this secondary analysis of the April trial, we looked at the placenta of the previous spontaneous preterm birth.
The APRIL trial showed a non significant reduction in recurrent preterm birth when women used low dose aspirin after a previous preterm birth.
In our analysis, low dose aspirin in the next pregnancy was associated with far fewer recurrent preterm births in women whose previous placenta showed signs of maternal vascular malperfusion (MVM): 4 percent (1 24) with aspirin vs. 45 percent (9 20) with placebo.
In women without MVM, we saw no benefit.
As a post hoc analysis with small numbers, these findings are hypothesis generating and need confirmation in a prospective trial.
Still, they support the idea that spontaneous preterm birth is not one condition, but the outcome of several underlying causes.
Placental histology may help identify a vascular mediated subgroup that could benefit from aspirin.
Thank you to all co authors, the APRIL study group, the participating centres and, of course, all participants!”
Title: Low-Dose Aspirin in the Prevention of Recurrent Spontaneous Preterm Birth Stratified by Placental Maternal Vascular Malperfusion: Secondary Analysis of a Randomized Trial
Authors: James A. L. Meliëzer, Anadeijda J. E. M. C. Landman, Adelia A. Gieskes, Marianna Bugiani, Laura Visser, Mireille N. Bekker, Judith O. E. H. van Laar, Marieke Sueters, Sanne J. Gordijn, Joris van Drongelen, J. Marko Sikkema, Wietske Hermes, Anjoke J. M. Huisjes, Dimitri N. M. Papatsonis, Janine Boon, Joost J. Zwart, Christianne J. M. de Groot, Martijn A. Oudijk, Marjon A. de Boer 
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 31, 2026, 12:21Niksa Bagheri: Key Shear Regimes and Physics Selection for Continuum Thrombosis Modeling
-
Oct 31, 2026, 12:14Ghaith Abu-Zeinah: International MPN Congress Honors the Life and Legacy of MPN Pioneer Dr. Richard T. Silver
-
Oct 31, 2026, 12:11Thierry Burnouf: Taipei Medical University and University of Lille Highlight Platelet Biotherapies in SfN Neuronline
-
Oct 31, 2026, 12:07Eamon Faulkner: How Oxygen Shapes Platelet–Endothelial Interactions
-
Oct 31, 2026, 12:01Abdul Mannan: IVIG in ITP – When a Temporary Response Is a Success
-
Oct 31, 2026, 11:52Breaking the Silence Around Bleeding Disorders in Women – National Bleeding Disorders Foundation
-
Oct 31, 2026, 11:10Elly De Bruyn: QbD Group Quiz Supports the World Federation of Hemophilia
-
Oct 31, 2026, 11:04Abhivandan Nagia: The Expanding Clinical Pipeline in Hemophilia A
-
Oct 31, 2026, 10:54Bartosz Puła: New Advances in Hematology Featured in Acta Haematologica Polonica